Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 7—July 2008

Importation of West Nile Virus Infection from Nicaragua to Spain

Begoña Monge Maillo*, Rogelio López-Vélez*Comments to Author , Francesca F. Norman*, Fernando de Ory†, María Paz Sanchez-Seco†, and Cesare Giovanni Fedele†
Author affiliations: *Ramon y Cajal Hospital, Madrid, Spain; †Instituto de Salud Carlos III, Madrid;

Main Article


Serologic results for antibodies to West Nile virus (WNV), dengue virus (DV), and tick-borne encephalitis virus (TBEV)*

d after onset WNV
IgG† IgG‡ IT-IgG§ IgM† Ab‡ IT Ab¶ IgG† IgM† IgG† IgM†
S1/13 3.5 65,000 3.54 3.6 256 7.0 4.8 0.3 59.5 0.1
CSF/13 4,000 Pos# 32
S2/160 3.2 16,000 0.8 64 4.5 0.2 27 0.1

*PRNT, plaque reduction neutralization assay; Ig, immunoglobulin; Ab, antibodies; IT, intrathecal; S1, first serum sample, obtained 13 days after onset of symptoms; CSF, cerebrospinal fluid; Pos, positive; S2, second serum sample, obtained 160 days after onset of symptoms.
†Results expressed as the ratio of sample absorbance to cutoff value (positive >1.0).
§IT production of WNV IgG (ELISA).
¶IT production of WNV antibodies (PRNT).
#CSF tested diluted 1:2.

Main Article

Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.